How to Address Cross-Contamination in GMP Manufacturing for Biologics
How to Address Cross-Contamination in GMP Manufacturing for Biologics Strategies to Prevent Cross-Contamination in Biologics Manufacturing Under GMP Introduction: The Complexity of Biologics Manufacturing and Cross-Contamination Risks Biologics manufacturing involves complex processes, including cell culture, fermentation, and purification, that make it particularly vulnerable to cross-contamination. Unlike small-molecule drugs, biologics are produced from living organisms, requiring…
Read More “How to Address Cross-Contamination in GMP Manufacturing for Biologics” »